Comments to HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances
November 13, 2026
November 13, 2026
WASHINGTON, Nov. 13 [Category: ThinkTank] -- The American Action Forum issued the following news release:
* * *
Comments to HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances
*
The Department of Health and Human Services' (HHS) announced an interim enforcement discretion policy, under Section 503A of the Federal Food, Drug, and Cosmetic Act, concerning the compounding of six non-FDA app . . .
* * *
Comments to HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances
*
The Department of Health and Human Services' (HHS) announced an interim enforcement discretion policy, under Section 503A of the Federal Food, Drug, and Cosmetic Act, concerning the compounding of six non-FDA app . . .